WHAT YOU NEED TO KNOW:
- The US FDA announced a shortage of amphetamine mixed salts, commonly known by the brand name Adderall.
- Adderall is a drug used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
- Other manufacturers continue to produce amphetamine mixed salts, but there is not enough supply to continue to meet the demand.
The U.S. Food and Drug Administration announced Wednesday that there is a nationwide shortage of Adderall. The drug is used to treat attention deficit hyperactivity disorder(ADHD), following intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd, maker of Adderall.
The FDA said in a release on Wednesday that Teva Pharmaceuticals has cited manufacturing delays for the shortage and difficulty meeting a surge in demand.
The agency added that other manufacturers are continuing to produce Adderall, but there is not enough supply to meet the country’s current needs. According to analysts, it is difficult for pharmacies to immediately switch to other brands of the drug because it is a controlled substance and highly regulated.
Teva Pharmaceuticals said that the company is refilling its supply of the drug “at levels above historic demand.” The company has noted that their inventory is expected to recover from the shortage “in coming months.”
Dr. David Goodman, director of the Adult Attention Deficit Disorder Center of Maryland, said that 4% of adults and 8% of children have ADHD and about 70% of adults and 40% of children go untreated.
Increasing awareness about ADHD has led to a surge in demand for Adderall.
“I can understand why there are shortages because there’s an increased demand of people who are seeking these medications,” Goodman, an assistant professor of psychiatry at Johns Hopkins University School of Medicine said.
The FDA recommends that patients in need of Adderall contact their healthcare providers to determine the best treatment option.
Source: NBC News